June 17, 2017

Hansa Medical

We feel BEARISH on the markets.

“It’s waiting that helps you as an investor, and a lot of people just can’t stand to wait.” – Charlie Munger
HMED.ST (ISIN: SE0002148817)

Hansa Medical AB is a Sweden-based research company focused on the development of biopharmaceuticals and diagnostics within inflammation.  

Market: Stockholm

http://www.scapa.com/ 




Gain over the last quarter: +0.0 % 


Fair value: 187.5 SEK
Premium: 6%
Average yearly return: 62%
Yield: N/A
Outperformer

On May 31, 2017:
Increase of number of shares and votes in Hansa Medical AB (publ)

No comments:

Post a Comment